The PCE Price Index year over year rose 2.6% in December, in line with forecasts and following an increase of 2.4% in ...
Progress on inflation was "noticeably" slower last year than in 2023, and upside risks to higher price pressures remain, and therefore the U.S. central bank should adopt a cautious and gradual ...
AbbVie Inc.'s stock rose 4% early Friday, after the drug company beat fourth-quarter earnings estimates and offered an upbeat view of 2025, as its newer immunology drugs delivered growth needed to ...
AbbVie saw fourth-quarter sales handily beat Wall Street's projections as gains from its newer anti-inflammatory drugs helped offset declines from Humira, once its best performing asset. The drugmaker ...